{"title":"物质使用障碍和共病COVID-19感染患者的维持治疗会导致不良后果吗?","authors":"John Arianda Owiti","doi":"10.24966/aad-7276/100122","DOIUrl":null,"url":null,"abstract":"The safety of Opioid Substitution Therapy (OST) for the treatment of Substance Use Disorder (SUD) in people with Coronavirus Disease 2019 (COVID-19) is not well understood. People with SUD are typically disengaged with healthcare and have multiple comorbidities. Further, opioids are respiratory depressants and could exacerbate respiratory difficulties arising from COVID-19.","PeriodicalId":359765,"journal":{"name":"Journal of Addiction & Addictive Disorders","volume":"27 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-07-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Does Maintenance Therapy for Patients with Substance Use Disorder and Comorbid COVID-19 Infection lead to Adverse Outcomes?\",\"authors\":\"John Arianda Owiti\",\"doi\":\"10.24966/aad-7276/100122\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The safety of Opioid Substitution Therapy (OST) for the treatment of Substance Use Disorder (SUD) in people with Coronavirus Disease 2019 (COVID-19) is not well understood. People with SUD are typically disengaged with healthcare and have multiple comorbidities. Further, opioids are respiratory depressants and could exacerbate respiratory difficulties arising from COVID-19.\",\"PeriodicalId\":359765,\"journal\":{\"name\":\"Journal of Addiction & Addictive Disorders\",\"volume\":\"27 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Addiction & Addictive Disorders\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.24966/aad-7276/100122\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Addiction & Addictive Disorders","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.24966/aad-7276/100122","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Does Maintenance Therapy for Patients with Substance Use Disorder and Comorbid COVID-19 Infection lead to Adverse Outcomes?
The safety of Opioid Substitution Therapy (OST) for the treatment of Substance Use Disorder (SUD) in people with Coronavirus Disease 2019 (COVID-19) is not well understood. People with SUD are typically disengaged with healthcare and have multiple comorbidities. Further, opioids are respiratory depressants and could exacerbate respiratory difficulties arising from COVID-19.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
